Exelixis (EXEL) Non-Current Debt (2010 - 2016)
Exelixis' (EXEL) quarterly Non-Current Debt came in at $80.0 million in Q1 2016, little changed year-on-year from $80.0 million in Q2 2015, and little changed quarter-over-quarter from $80.0 million in Q4 2015.
Exelixis (EXEL) Non-Current Debt (2010 - 2016) Analysis & Trends
Exelixis' Non-Current Debt history runs 7 years deep, the most recent figure standing at $80.0 million for Q1 2016.
- On a quarterly basis, Non-Current Debt changed 0.0% year-over-year to $80.0 million in Q1 2016; TTM through Mar 2016 was $80.0 million, a 0.0% change from a year earlier, with the FY2015 full-year figure at $80.0 million, changed 0.0% from the prior year.
- Non-Current Debt was little changed at $80.0 million in Q1 2016 per EXEL's latest filing, from $80.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $84.5 million in Q1 2012 and bottomed at $80.0 million in Q3 2014.
- The 5-year median for Non-Current Debt is $80.2 million (2014), against an average of $81.0 million.
- Across the five-year window, Non-Current Debt decreased 3.72% in 2012 and changed 0.0% in 2015, its largest moves.
- Year by year, Non-Current Debt stood at $82.1 million in 2012, then slipped by 2.15% to $80.3 million in 2013, then dropped by 0.41% to $80.0 million in 2014, then changed by 0.0% to $80.0 million in 2015, then changed by 0.0% to $80.0 million in 2016.
- Per Business Quant, the three latest EXEL Non-Current Debt figures stand at $80.0 million (Q1 2016), $80.0 million (Q4 2015), and $80.0 million (Q3 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 80.00 Mn |
| Dec 31, 2015 | 80.00 Mn |
| Sep 30, 2015 | 80.00 Mn |
| Jun 30, 2015 | 80.00 Mn |
| Mar 31, 2015 | 80.00 Mn |
| Dec 31, 2014 | 80.00 Mn |
| Sep 30, 2014 | 80.00 Mn |
| Jun 30, 2014 | 80.06 Mn |
| Mar 31, 2014 | 80.22 Mn |
| Dec 31, 2013 | 80.33 Mn |
| Sep 30, 2013 | 80.76 Mn |
| Jun 30, 2013 | 81.13 Mn |
| Mar 31, 2013 | 81.61 Mn |
| Dec 31, 2012 | 82.09 Mn |
| Sep 30, 2012 | 82.89 Mn |
| Jun 30, 2012 | 83.68 Mn |
| Mar 31, 2012 | 84.47 Mn |
| Dec 31, 2011 | 85.26 Mn |
| Sep 30, 2011 | 85.79 Mn |
| Jun 30, 2011 | 86.57 Mn |